{"id":"W2122865912","doi":"10.1161/01.cir.0000087447.12918.85","title":"Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":320,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Heart Institute; University of Alberta","funders":"Alexion Pharmaceuticals; Procter and Gamble","keywords":"Medicine; Bolus (digestion); Myocardial infarction; Placebo; Percutaneous coronary intervention; Cardiology; Internal medicine; Anesthesia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007102502,0.0004804406,0.00111409,0.0002696187,0.0002004337,0.0003718942,0.0003753684,0.0004424069,0.002169626],"category_scores_gemma":[0.0008679111,0.0001466784,0.0003448826,0.0002957072,0.0003365594,0.0001627009,0.0001818506,0.001095162,0.0002419445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004376876,"about_ca_system_score_gemma":0.000424374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006465351,"about_ca_topic_score_gemma":0.001914899,"domain_scores_codex":[0.9997035,0.0001492155,0.00002346177,0.0000343848,0.00004693806,0.00004247446],"domain_scores_gemma":[0.9996901,0.0001008324,0.00006336938,0.00001175684,0.00001883822,0.0001151385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6246946,0.02212025,0.02482203,0.002213766,0.002421482,0.00059139,0.0001640168,0.0008586474,0.04204614,0.0003371814,0.003416689,0.2763139],"study_design_scores_gemma":[0.4926124,0.3227657,0.1591015,0.0004638067,0.003169931,0.001311658,0.00008320847,0.001993778,0.01087671,0.0002962294,0.007294798,0.00003023886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98484,0.01233468,0.0002094494,0.0005043379,0.0001644995,0.0002931828,0.0001195159,0.00002627272,0.001508205],"genre_scores_gemma":[0.9936718,0.004418161,0.0004142516,0.0002721187,0.0003594849,0.0001699776,0.000179494,0.000002361558,0.0005123949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002169626,"threshold_uncertainty_score":0.007258177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02034240525581782,"score_gpt":0.3012870588420645,"score_spread":0.2809446535862467,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}